SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9821	Companies
197122	Keywords
128201	Articles
104839	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 10/09/2024 at 07:00, 1 year 4 months ago

Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants
Sanofi presents new Beyfortus data at IDWeek 2024, showcasing real-world effectiveness in protecting infants from RSV disease and hospitalization. Beyfortus doses shipped for 2024-2025 RSV season

Sanofi RSV Beyfortus Infants IDWeek
BRIEF

published on 09/27/2024 at 15:40, 1 year 4 months ago

Dupixent Approved in the US as First Biologic for COPD Patients

FDA Approval Clinical Studies COPD Dupixent Biologic Medicine
PRESS RELEASE

published on 09/27/2024 at 15:35, 1 year 4 months ago

Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
US FDA approves Dupixent as the first-ever biologic medicine for COPD, based on phase 3 studies showing significant reduction in exacerbations and improved lung function. Dupixent is now leading in new-to-brand prescriptions for FDA-approved indications

FDA Approval Dupixent COPD Treatment Biologic Medicine Phase 3 Studies
BRIEF

published on 09/27/2024 at 13:05, 1 year 4 months ago

Dupixent Authorized in China as First Biologic Medicine for COPD Patients

China Approval COPD Dupixent Biologic Medicine
PRESS RELEASE

published on 09/27/2024 at 13:00, 1 year 4 months ago

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Dupixent approved in China as the first-ever biologic medicine for COPD patients, following landmark phase 3 studies. Approval crucial for addressing COPD burden in China

China COPD Dupixent Biologic Medicine Phase 3 Studies
BRIEF

published on 09/21/2024 at 00:41, 1 year 4 months ago

Sarclisa Approved in the United States for the Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa First Line Treatment
BRIEF

published on 09/20/2024 at 13:50, 1 year 4 months ago

CHMP recommends approval of Dupixent for children aged 12 months and older

Children Medicine Dupixent CHMP Esophagitis
PRESS RELEASE

published on 09/20/2024 at 13:45, 1 year 4 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old based on positive phase 3 study results. Dupixent would be the first medicine indicated for EoE in this age group

Children Dupixent CHMP EU Approval Eosinophilic Esophagitis
BRIEF

published on 09/20/2024 at 11:35, 1 year 4 months ago

Sanofi's Tolebrutinib Shows Promise in Delaying Disability Progression in MS

Multiple Sclerosis ECTRIMS 2024 Tolebrutinib HERCULES Study Disability Progression
PRESS RELEASE

published on 09/20/2024 at 11:30, 1 year 4 months ago

Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study
Study shows tolebrutinib delays disability progression in non-relapsing secondary progressive MS by 31%; global regulatory submissions in H2 2024. ECTRIMS 2024 data presented

ECTRIMS 2024 Tolebrutinib Disability Progression Secondary Progressive MS Global Regulatory Submissions

Accesswire

Published on 02/09/2026 at 08:02, 38 minutes ago

Southern Energy Corp. Announces US$23.5 Million Financings and Royalty Sale
Published on 02/08/2026 at 21:00, 11 hours 40 minutes ago

Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 2 days 7 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 2 days 9 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days 10 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan

View all ACCESSWIRE

EQS Group

Published on 02/09/2026 at 08:30, 10 minutes ago

Successful year for Adler Group: Strategic realignment with focus on Berlin and structures adjusted in 2025. Long-term review of all future options without any time pressure
Published on 02/09/2026 at 08:00, 39 minutes ago

Transaction in Own Shares
Published on 02/09/2026 at 08:00, 39 minutes ago

Invitation to the media and analysts conference March 6, 2026
Published on 02/09/2026 at 08:00, 39 minutes ago

Custodian Property Income REIT plc: Block Listing interim review
Published on 02/09/2026 at 08:00, 40 minutes ago

Pyrum Innovations AG: France officially recognises pyrolysis oil from end-of-life tyres as a raw material for the chemical industry

Les Echos

Published on 02/09/2026 at 08:30, 10 minutes ago

THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer
Published on 02/09/2026 at 08:00, 40 minutes ago

Eiffage strengthen its expertise in the industrial refrigeration sector with the acquisition of a majority holding in the French company Quercy Réfrigération
Published on 02/06/2026 at 18:22, 2 days 14 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 16 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 3 days 13 hours ago

Minutes of the Combined General Meeting

View all LES ECHOS COMFI WIRE